Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-005683
Filing Date
2018-11-19
Accepted
2018-11-19 15:54:19
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oncx_10q.htm 10-Q 314109
2 CERTIFICATION oncx_ex311.htm EX-31.1 7369
3 CERTIFICATION oncx_ex321.htm EX-32.1 2959
  Complete submission text file 0001477932-18-005683.txt   2124992

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT oncx-20180930.xml EX-101.INS 290837
5 XBRL TAXONOMY EXTENSION SCHEMA oncx-20180930.xsd EX-101.SCH 38409
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oncx-20180930_cal.xml EX-101.CAL 27475
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oncx-20180930_def.xml EX-101.DEF 134108
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE oncx-20180930_lab.xml EX-101.LAB 173985
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oncx-20180930_pre.xml EX-101.PRE 166048
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

EIN.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55545 | Film No.: 181192471
SIC: 2834 Pharmaceutical Preparations